Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment option ... Show More
Oct 8
Evolving Strategies in Aortic Arch Repair
Eric Roselli, MD, and Patrick Vargo, MD, discuss how advances in open, hybrid and endovascular techniques are changing the treatment of aortic arch disease. They explore evolving approaches to aneurysms and dissections, innovations in brain protection and the role of specialized ... Show More
23m 49s
Oct 1
Management of Complex Aortic Valve Endocarditis
Milind Desai, MD, and Per Wierup, MD, discuss the evaluation and management of high-risk aortic valve endocarditis, including indications for urgent intervention and timing of surgery. They also review operative approaches to patients with heart failure, uncontrolled infection an ... Show More
13m 34s
Sep 24
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular risk and how ongoing phase 3 re ... Show More
9m 8s
Aug 2024
386. Beyond the Boards: Cardiomyopathies with Dr. Steve Ommen
CardioNerds (Drs. Teodora Donisan, Jenna Skowronski, and Johnny Hourmozdi) discuss Cardiomyopathies with Dr. Steve Ommen. Through a case-based discussion, we review the diagnostic evaluation of suspected restrictive cardiomyopathy, and Dr. Ommen shares his expertise in the nuance ... Show More
37m 30s
Dec 2019
3. Hypertrophic Cardiomyopathy: Case Discussion
The CardioNerds discuss a case of hypertrophic cardiomyopathy teaching a comprehensive approach to pathophysiology, diagnosis, imaging, and management of hypertrophic cardiomyopathy. Guest host, Dr. Fatimah Alkhunaizi. Flutter moment by Dr. Virginia Hahn (Cardiology). On the Card ... Show More
52m 59s
Sep 2025
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More
31m 4s